Tactile Systems Technology (NASDAQ:TCMD) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Tactile Systems Technology (NASDAQ:TCMD) issued its quarterly earnings results on Monday. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.01), FiscalAI reports. Tactile Systems Technology had a net margin of 5.91% and a return on equity of 9.84%. The company had revenue of $75.27 million during the quarter, compared to analysts’ expectations of $70.57 million.

Here are the key takeaways from Tactile Systems Technology’s conference call:

• Q1 revenue $75.3M (+23% YoY) with lymphedema $62.2M and airway clearance $13M, and management raised full?year revenue guidance to $360–$368M.
• Profitability expanded — gross margin improved 250 basis points to 76.5% and Adjusted EBITDA turned positive at $3.7M (guidance of $49–$51M for 2026), reflecting operating leverage from commercial and operational investments.
• The new Medicare prior authorization rollout is causing short?term variability and some MAC?to?MAC differences; management expects a lighter Q2 cadence with normalization into Q3 and is modestly conservative in modeling until approval data stabilizes.
• Strategic innovation and M&A progress — LymphaTech integration is on track (including a federal GUIDE grant), the company accelerated an AI prior?authorization module, and won FDA 510(k) clearance for a next?gen AffloVest slated for the 2026–27 respiratory season.

Tactile Systems Technology Price Performance

Shares of TCMD opened at $24.05 on Wednesday. The firm has a 50-day simple moving average of $26.33 and a two-hundred day simple moving average of $26.10. The stock has a market cap of $547.14 million, a PE ratio of 27.33 and a beta of 0.82. Tactile Systems Technology has a 1-year low of $8.61 and a 1-year high of $37.77.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Lake Street Capital set a $40.00 target price on Tactile Systems Technology and gave the company a “buy” rating in a report on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Tactile Systems Technology in a research note on Friday, March 27th. Piper Sandler boosted their price target on Tactile Systems Technology from $35.00 to $42.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 18th. B. Riley Financial increased their price objective on Tactile Systems Technology from $16.00 to $32.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Finally, BTIG Research lifted their target price on shares of Tactile Systems Technology from $38.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $37.80.

Insider Buying and Selling

In related news, CFO Elaine M. Birkemeyer sold 7,701 shares of the stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $28.94, for a total transaction of $222,866.94. Following the completion of the transaction, the chief financial officer owned 134,819 shares of the company’s stock, valued at approximately $3,901,661.86. This trade represents a 5.40% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Kristie Burns sold 6,246 shares of Tactile Systems Technology stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $28.94, for a total transaction of $180,759.24. Following the completion of the sale, the vice president owned 82,581 shares of the company’s stock, valued at $2,389,894.14. This trade represents a 7.03% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 50,137 shares of company stock valued at $1,434,839. Company insiders own 2.10% of the company’s stock.

Institutional Investors Weigh In On Tactile Systems Technology

Institutional investors and hedge funds have recently modified their holdings of the company. Prudential Financial Inc. increased its stake in Tactile Systems Technology by 3.5% during the second quarter. Prudential Financial Inc. now owns 24,360 shares of the company’s stock worth $247,000 after purchasing an additional 835 shares during the period. Occudo Quantitative Strategies LP acquired a new stake in shares of Tactile Systems Technology during the fourth quarter worth about $242,000. Cresset Asset Management LLC lifted its position in shares of Tactile Systems Technology by 14.3% during the second quarter. Cresset Asset Management LLC now owns 22,894 shares of the company’s stock worth $232,000 after purchasing an additional 2,858 shares in the last quarter. PharVision Advisers LLC purchased a new position in shares of Tactile Systems Technology in the third quarter valued at approximately $177,000. Finally, Mercer Global Advisors Inc. ADV purchased a new position in shares of Tactile Systems Technology in the third quarter valued at approximately $144,000. Hedge funds and other institutional investors own 83.43% of the company’s stock.

Key Tactile Systems Technology News

Here are the key news stories impacting Tactile Systems Technology this week:

• Positive Sentiment: Q1 results: revenue up 23% to $75.3M (beat consensus), gross margin improved to 76.5%, net loss narrowed and adjusted EBITDA was positive $3.7M — demonstrates stronger underlying profitability and demand. Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results
• Positive Sentiment: FY?2026 revenue guidance of $360M–$368M and management’s commentary that the Medicare prior?authorization process is maturing provide revenue visibility and suggest easier reimbursement execution ahead for their PCD business. Tactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process matures
• Positive Sentiment: Analyst upgrade: BTIG raised its price target to $40 and maintained a Buy — a bullish signal that may attract demand and support the rally. Benzinga The Fly
• Positive Sentiment: Product and capital actions: received FDA 510(k) for next?gen AffloVest and repurchased $1.1M of stock — both support product pipeline and shareholder return narratives. Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results
• Neutral Sentiment: Full earnings call and transcript are available for further color on Medicare execution, margin drivers, and cadence of orders — useful for investors who want management detail. Q1 2026 Earnings Call Transcript Q1 2026 Earnings Transcript (Yahoo)
• Negative Sentiment: Slight EPS miss: reported loss of ($0.08) vs. consensus ($0.07) — a minor headline miss that some short?term traders may focus on despite the revenue beat and margin improvement. Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates

About Tactile Systems Technology

Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.